Newsroom
Publications
Our interdisciplinary team of dedicated scientists can boast of various technical publications. In addition, several publications are in the pipeline. If you need further information, please do not hesitate to contact us.
Badenhorst, M. et al. An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus Inoculation. Viruses 14, 1401 (2022).
Wahl, L.; Raschke, M.; Wittmann, J.; Regler, A.; Heelemann, S.; Brandsch, C.; Stangl, G.I.; Vervuert, I.: Effects of atherogenic diet supplemented with fermentable carbohydrates on metabolic responses and plaque formation in coronary arteries using a Saddleback pig model. PLOS ONE. 2022, 17(10):e0275214.
Wilmer, L., Tränkner, M., Pawelzik, E. & Naumann, M. Sufficient potassium supply enhances tolerance of potato plants to PEG-induced osmotic stress. Plant Stress 5, 100102 (2022).
Kanski, L.; Kahle, H.; Naumann, M.; Hagenguth, J.; Ulbrich, A.; Pawelzik, E.: Cultivation Systems, Light Intensity, and Their Influence on Yield and Fruit Quality Parameters of Tomatoes. Agronomy. 2021, 11, 1203.
Chea, L.; Pfeiffer, B.; Schneider, D.; Daniel, R.; Pawelzik, E.; Naumann, M.: Morphological and Metabolite Responses of Potatoes under Various Phosphorus Levels and Their Amelioration by Plant Growth‐Promoting Rhizobacteria. Int. J. Mol. Sci. 2021, 22, 5162.
Westermeier, P.; Albrecht, T.; Geyer, R.; Willner, E. and Hartmann, S.: Analysis of drought tolerance in perennial ryegrass (Lolium perenne L.) with methods of genomic prediction. Grassland Sci Europe, 2019, 24, 421-423.
Geyer, R.; Eickmeyer, F.; Rettig, M.; Heelemann, S.; Kirchhöfer, R.: Bedeutung einer effizienten Charakterisierung pflanzlicher Extrakte für die Züchtung und den Übergang von der Wildsammlung zum kontrollierten Anbau. Julius-Kühn-Archiv. 2018, 460, 72-75.
Cooperations
Press and media
- All
- Meet us
- Press and media
Interview with Dr. Ali Tinazli at MedTech Insights
Interview “Spinning Around – One Company’s Bid To Diagnostic-ify The Metabolism”
Interview with Dr. Ali Tinazli at “The Health 2.0 Conference” in Dubai
Interview with Dr. Ali Tinazli at Health 2.0 Conference
Revolutionizing Healthcare with AI-Driven Diagnostics
MediWord: An Inverview with CEO Dr. Ali Tinazli
Lifespin Announces the Launch of its First Commercial Product in Regulated Healthcare
Lifespin Amino Acid Profiler™
Lifespin partners with the Leipzig Research Center for Civilization Diseases (LIFE) to obtain deep clinical insights for obesity and diabetes
8,000 patient samples to be digitized and studied for metabolic patterns
Lifespin Announces Inaugural Membership in the Industrial Participant Program of the Wyss Diagnostics Accelerator at Harvard University
Wyss Diagnostics Accelerator seeks to fast-track disruptive diagnostic technologies to meet unmet critical needs
Lifespin Granted ISO13485 Certification for Its Proprietary A.I.-based Metabolomics Platform for In Vitro Diagnostics
ISO13485 certification represents a key milestone towards achieving market-readiness of its automated, high-volume testing infrastructure and ability to build affordable and scalable omics-based precision medicine tools
New Tech Could Improve Diagnostic Accuracy of Prostate Cancer Tests
Dr. Ali Tinazli’s article about “New Tech Could Improve Diagnostic Accuracy of Prostate Cancer Tests”
The Crucial Role Of Predictive Analytics In Precision Medicine
Dr. Ali Tinazli’s post at the Forbes magazine about “The Crucial Role Of Predictive Analytics In Precision Medicine”
History Of Health Technologies And Meaningful Change In The Era Of Health 4.0
Dr. Ali Tinazli’s post at the Forbes magazine about “History Of Health Technologies And Meaningful Change In The Era Of Health 4.0”
How Technology, Early Diagnoses Can Help Turn The Tide On Prostate Cancer Prognosis
Dr. Ali Tinazli’s post at the Forbes magazine about “How Technology, Early Diagnoses Can Help Turn The Tide On Prostate Cancer Prognosis”
Lifespin Announces Expansion of Laboratory Testing Capability
New investments in testing infrastructure will enable Lifespin to analyze up to 300,000 patient samples …
Lifespin Launches Commercial Access to its Metabolic Profiler Software and Database for Pharma and Biobank Services
New commercial services will provide powerful insights to aid in research, development, and manufacturing by …
Why Knowledge Is Power In The Treatment Of Obesity
Dr. Ali Tinazli’s post at the Forbes magazine about “Why Knowledge Is Power In The Treatment Of Obesity”
lifespin GmbH as inaugural member of the Wyss Diagnostics Accelerator
lifespin GmbH announced as inaugural member of the Wyss Diagnostics Accelerator (Wyss DxA) Industrial Participant Program (IPP) at Harvard University.
How Lifespin revolutionizes the diagnosis of diseases with metabolic information and artificial intelligence
An interview by 5-HT Digital Hub Chemistry & Health with Dr. Ali Tinazli
Lifespin Significantly Expands its Proprietary Database of Human Health Profiles in Oncology Under Newly Established Cooperative Scientific Agreement with the Medical University of Graz
lifespin’s agreement with Medical University Graz which garants access to more than 25,000 longitudinal blood samples